Medical Research
(H30)
990 on File
JED IAN TAXEL FOUNDATION FOR RARE CANCER RESEARCH INC
Financial strength (30%)
66/100
Reliability (20%)
45/100
Effectiveness (25%)
68/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$309K
Total Revenue
$394K
Total Expenses
$114K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
69.1%
Fundraising Efficiency
84.5%
Operating Reserve
3.48x
Liability-to-Asset
23.2%
Revenue Diversification
79.5%
Executive Compensation
$40K
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
69.1% | 84.5% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
17.4% | 11.4% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
13.6% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
84.5% | 10.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
3.5 mo | 13.4 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
23.2% | 0.4% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
79.5% | 93.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
12.9% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
36.5% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-27.4% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $309K | $394K | $114K | 69.1% | 0 |
| 2023 | $274K | $288K | $199K | 60.3% | 0 |
| 2022 | $361K | $430K | $214K | 57.5% | 0 |
| 2021 | $363K | $80K | $283K | 29.6% | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.